Taken together, these data support a prominent role of CXCR2/CXCL1 axis in the recruitment of PMN-MDSC in melanoma, indicating this receptor as an ideal target for blocking migration of these cells without impairing the trafficking of tumor-reactive effector immune cells. The gene discussed is CXCL1; the disease is neoplasm.